Small Cell Lung Carcinoma (SCLC)
Oncology·MeSH: Small Cell Lung Carcinoma
5 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Topotecan | Merus N.V. (MRUS) |
Phase 1(2)
N/A(1)
Phase 4(1)
| Drug | Company |
|---|---|
| Single agent chemotherapy | Merus N.V. (MRUS) |
Compare drugs
Frequently asked questions
How many drugs are in development for Small Cell Lung Carcinoma (SCLC)?
BioSniper tracks 5 drugs in development for Small Cell Lung Carcinoma (SCLC) across 1 company.
How many clinical trials target Small Cell Lung Carcinoma (SCLC)?
There are 1 clinical trial targeting Small Cell Lung Carcinoma (SCLC) tracked by BioSniper.
Deep-dive into Small Cell Lung Carcinoma (SCLC)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis